Novel physiolgically active substances
Details for Australian Patent Application No. 2003241927 (hide)
International Classifications
Event Publications
11 September 2003 Complete Application Filed
Priority application(s): 2003-63176 10.03.03 JP; 2002-155853 29.05.02 JP; 2002-223355 31.07.02 JP
5 February 2004 Application Open to Public Inspection
Published as AU-B-2003241927
7 June 2007 Assignment before Grant
Eisai Co., Ltd.; Mercian Corporation The application has been assigned to Mercian Corporation; Eisai R&D Management Co., Ltd.
18 June 2009 Application Accepted
Published as AU-B-2003241927
16 July 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 03 Jun 2009. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000
23 July 2009 Corrigenda
Applications Accepted - Name Index Under the name Mercian Corporation; Eisai Corrigenda R&D Management Co., Ltd., Application No. 2003241927, under INID (72) correct the co-inventor to Fukuda, Yoshio
5 November 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 03 Jun 2009
12 November 2009 Standard Patent Sealed
8 March 2012 Assignment Registered
Eisai R&D Management Co., Ltd.; Mercian Corporation The patent has been assigned to MicroBiopharm Japan Co., Ltd.; Eisai R&D Management Co., Ltd.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser